Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interferon beta

Haile, Lydia Asrat; Polumuri, Swamy Kumar; Rao, Roshni; Kelley-Baker, Logan; Kryndushkin, Dimitri; Rajaiah, Rajesh; Israely, Tomer; Rao, V. Ashutosh; Verthelyi, Daniela

doi:10.1038/s41598-017-09981-w

Title: Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interferon beta

Journal Article · Tue Sep 05 00:00:00 EDT 2017 · Scientific Reports

DOI:https://doi.org/10.1038/s41598-017-09981-w· OSTI ID:1624331

Haile, Lydia Asrat ^[1]; Polumuri, Swamy Kumar ^[1]; Rao, Roshni ^[1]; Kelley-Baker, Logan ^[1]; Kryndushkin, Dimitri ^[1]; Rajaiah, Rajesh ^[1]; Israely, Tomer ^[1]; Rao, V. Ashutosh ^[1]; Verthelyi, Daniela ^[1]

U.S. Food and Drug Administration (FDA), Silver Spring, MD (United States). Center for Drug Evaluation and Research. Office of Biotechnology Products. Division of Biotechnology Review and Research III. Lab of Immunology

Immunogenicity can have devastating consequences on the safety and efficacy of therapeutic proteins. Therefore, evaluating and mitigating the risk of product immunogenicity is critical for the development these products. This study, showed that Betaseron and Extavia, which are reported to be more immunogenic among IFNβ products in clinical usage, contain residual innate immune response modulating impurities (IIRMIs) capable of activating NF-κB and induced expression of infammatory mediators. These IIRMIs were undetectable in Rebif or Avonex. The stimulatory efect was attributed solely to IIRMIs because it was evident in murine cells lacking the interferon receptor (IFNAR). The IIRMIs in Betaseron and Extavia triggered NF-κB activation in HEK-293 cells bearing TLR2 and TLR4 in MyD88 dependent manner. Importantly, the IIRMIs in Betaseron induced up-regulation of IL-6, IL-1β, and ccl5 in the skin of IFNAR knock out mice following subcutaneous administration. This indicates that trace level IIRMIs in Betaseron could contribute to the higher immunogenicity rates seen in clinics. Together these data suggest that cell based assays can reveal subtle but clinically relevant differences in IIRMIs following manufacturing changes or between products with the same active ingredients but different manufacturing processes. Appreciating these differences may inform immunogenicity risk assessments.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)

Sponsoring Organization:: USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division

Grant/Contract Number:: SC0014664

OSTI ID:: 1624331

Journal Information:: Scientific Reports, Vol. 7, Issue 1; ISSN 2045-2322

Publisher:: Nature Publishing GroupCopyright Statement

Country of Publication:: United States

Language:: English

References (52)

Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model Moussa, E. M.; Kotarek, J.; Blum, J. S. Pharmaceutical Research, Vol. 33, Issue 7 https://doi.org/10.1007/s11095-016-1914-4	journal	April 2016
Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems Reich, Johannes; Lang, Pierre; Grallert, Holger Biologicals, Vol. 44, Issue 5 https://doi.org/10.1016/j.biologicals.2016.04.012	journal	September 2016
Immunomodulatory activity of interferon‐beta Kasper, Lloyd H.; Reder, Anthony T. Annals of Clinical and Translational Neurology, Vol. 1, Issue 8 https://doi.org/10.1002/acn3.84	journal	July 2014
Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction Kishnani, Priya S.; Dickson, Patricia I.; Muldowney, Laurie Molecular Genetics and Metabolism, Vol. 117, Issue 2 https://doi.org/10.1016/j.ymgme.2015.11.001	journal	February 2016
Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2 Hirschfeld, Matthew; Ma, Ying; Weis, John H. The Journal of Immunology, Vol. 165, Issue 2 https://doi.org/10.4049/jimmunol.165.2.618	journal	July 2000
Immunologic Therapy of Multiple Sclerosis Arnason, MD, Barry G. W. Annual Review of Medicine, Vol. 50, Issue 1 https://doi.org/10.1146/annurev.med.50.1.291	journal	February 1999
Pattern Recognition Receptors and Inflammation Takeuchi, Osamu; Akira, Shizuo Cell, Vol. 140, Issue 6 https://doi.org/10.1016/j.cell.2010.01.022	journal	March 2010
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory Bertolotto, A. Journal of Neurology, Neurosurgery & Psychiatry, Vol. 73, Issue 2 https://doi.org/10.1136/jnnp.73.2.148	journal	August 2002
Monocyte Activation Test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin [EN] Perdomo-Morales, Rolando ALTEX, Vol. 28, Issue 3 https://doi.org/10.14573/altex.2011.3.227	journal	January 2011
Cooperation of Toll-like receptor signals in innate immune defence Trinchieri, Giorgio; Sher, Alan Nature Reviews Immunology, Vol. 7, Issue 3 https://doi.org/10.1038/nri2038	journal	March 2007
Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients Bertolotto, A.; Gilli, F.; Sala, A. Neurology, Vol. 60, Issue 4 https://doi.org/10.1212/01.wnl.0000046662.03894.c5	journal	February 2003
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells Napolitani, Giorgio; Rinaldi, Andrea; Bertoni, Francesco Nature Immunology, Vol. 6, Issue 8 https://doi.org/10.1038/ni1223	journal	July 2005
Application of High Hydrostatic Pressure to Dissociate Aggregates and Refold Proteins Seefeldt, Matthew; Rosendahl, Mary; Cleland, Jeffrey Current Pharmaceutical Biotechnology, Vol. 10, Issue 4 https://doi.org/10.2174/138920109788488914	journal	June 2009
Managing uncertainty: A perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins Rosenberg, Amy S.; Verthelyi, Daniela; Cherney, Barry W. Journal of Pharmaceutical Sciences, Vol. 101, Issue 10 https://doi.org/10.1002/jps.23244	journal	October 2012
Frequency and Magnitude of Interferon β Neutralizing Antibodies in the Evaluation of Interferon β Immunogenicity in Patients with Multiple Sclerosis Grossberg, Sidney E.; Oger, Joel; Grossberg, Leslie D. Journal of Interferon & Cytokine Research, Vol. 31, Issue 3 https://doi.org/10.1089/jir.2010.0038	journal	March 2011
TLR-based immune adjuvants Steinhagen, Folkert; Kinjo, Takeshi; Bode, Christian Vaccine, Vol. 29, Issue 17 https://doi.org/10.1016/j.vaccine.2010.08.002	journal	April 2011
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development Hegen, H.; Millonig, A.; Bertolotto, A. Multiple Sclerosis Journal, Vol. 20, Issue 5 https://doi.org/10.1177/1352458513503597	journal	September 2013
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics Singh, Satish Kumar Journal of Pharmaceutical Sciences, Vol. 100, Issue 2 https://doi.org/10.1002/jps.22276	journal	February 2011
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis Petkau, A. John; White, Richard A.; Ebers, George C. Multiple Sclerosis Journal, Vol. 10, Issue 2 https://doi.org/10.1191/1352458504ms1004oa	journal	April 2004
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs Shankar, Gopi; Pendley, Charles; Stein, Kathryn E. Nature Biotechnology, Vol. 25, Issue 5 https://doi.org/10.1038/nbt1303	journal	May 2007
Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates Haji Abdolvahab, Mohadeseh; Fazeli, Ahmad; Halim, Andhyk Journal of Interferon & Cytokine Research, Vol. 36, Issue 4 https://doi.org/10.1089/jir.2015.0108	journal	April 2016
Influence of Escherichia coli chaperone DnaK on protein immunogenicity Ratanji, Kirsty D.; Derrick, Jeremy P.; Kimber, Ian Immunology, Vol. 150, Issue 3 https://doi.org/10.1111/imm.12689	journal	December 2016
CD8 ⁺ T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c ⁺ Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling Lindsay, Ross W. B.; Darrah, Patricia A.; Quinn, Kylie M. The Journal of Immunology, Vol. 185, Issue 3 https://doi.org/10.4049/jimmunol.1000338	journal	July 2010
Beta-interferon for multiple sclerosis Rudick, Richard A.; Goelz, Susan E. Experimental Cell Research, Vol. 317, Issue 9 https://doi.org/10.1016/j.yexcr.2011.03.002	journal	May 2011
Analytical techniques and bioactivity assays to compare the structure and function of filgrastim (granulocyte-colony stimulating factor) therapeutics from different manufacturers Levy, Michaella J.; Gucinski, Ashley C.; Sommers, Cynthia D. Analytical and Bioanalytical Chemistry, Vol. 406, Issue 26 https://doi.org/10.1007/s00216-013-7469-x	journal	November 2013
Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins Haile, Lydia Asrat; Puig, Montserrat; Kelley-Baker, Logan PLOS ONE, Vol. 10, Issue 4 https://doi.org/10.1371/journal.pone.0125078	journal	April 2015
An Albumin-Free Formulation for Escherichia coli -Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice Abdolvahab, Mohadeseh Haji; Fazeli, Ahmad; Radmalekshahi, Mazda Journal of Interferon & Cytokine Research, Vol. 36, Issue 3 https://doi.org/10.1089/jir.2015.0110	journal	March 2016
Application of the Limulus Test for Practical Quality Control on Endotoxin Content in Commercial Human Serum Albumin (HSA) Products. In Comparison with the Rabbit Pyrogen Test [ヒト血清アルブミン製剤中のエンドトキシン量の測定に対するリムルス試験の応用.ウサギ発熱試験との比較] Asakawa, Sadao; Fujiwara, Hiroshi; Naito, Seishiro YAKUGAKU ZASSHI, Vol. 114, Issue 11 https://doi.org/10.1248/yakushi1947.114.11_888	journal	January 1994
Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo Zaitseva, Marina; Romantseva, Tatiana; Blinova, Ksenia Vaccine, Vol. 30, Issue 32 https://doi.org/10.1016/j.vaccine.2012.05.002	journal	July 2012
Endotoxin recovery using limulus amebocyte lysate (LAL) assay Bolden, Jay S.; Warburton, Rob E.; Phelan, Robert Biologicals, Vol. 44, Issue 5 https://doi.org/10.1016/j.biologicals.2016.04.009	journal	September 2016
Toll-like receptor 2 (TLR2) and dectin-1 contribute to the production of IL-12p40 by bone marrow-derived dendritic cells infected with Penicillium marneffei Nakamura, K.; Miyazato, A.; Koguchi, Y. Microbes and Infection, Vol. 10, Issue 10-11 https://doi.org/10.1016/j.micinf.2008.06.011	journal	August 2008
New FDA Draft Guidance on Immunogenicity Parenky, Ashwin; Myler, Heather; Amaravadi, Lakshmi The AAPS Journal, Vol. 16, Issue 3 https://doi.org/10.1208/s12248-014-9587-6	journal	March 2014
Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis van der Voort, Laura F. Archives of Neurology, Vol. 67, Issue 4 https://doi.org/10.1001/archneurol.2010.21	journal	April 2010
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies Ponce, Rafael; Abad, Leslie; Amaravadi, Lakshmi Regulatory Toxicology and Pharmacology, Vol. 54, Issue 2 https://doi.org/10.1016/j.yrtph.2009.03.012	journal	July 2009
Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice van Beers, Miranda M. C.; Sauerborn, Melody; Gilli, Francesca Pharmaceutical Research, Vol. 27, Issue 9 https://doi.org/10.1007/s11095-010-0172-0	journal	May 2010
The structure of human interferon- ? : implications for activity Karpusas, M.; Whitty, A.; Runkel, L. Cellular and Molecular Life Sciences (CMLS), Vol. 54, Issue 11 https://doi.org/10.1007/s000180050248	journal	November 1998
Comparative Effects of Metal-Catalyzed Oxidizing Systems on Carbonylation and Integrity of Therapeutic Proteins Kryndushkin, Dmitry; Rao, V. Ashutosh Pharmaceutical Research, Vol. 33, Issue 2 https://doi.org/10.1007/s11095-015-1807-y	journal	October 2015
Characterization and Quantitation of Aggregates and Particles in Interferon-β Products: Potential Links Between Product Quality Attributes and Immunogenicity Barnard, James G.; Babcock, Ken; Carpenter, John F. Journal of Pharmaceutical Sciences, Vol. 102, Issue 3 https://doi.org/10.1002/jps.23415	journal	March 2013
Immunogenicity of Biotherapeutics—An Overview Subramanyam, Meena Journal of Immunotoxicology, Vol. 3, Issue 3 https://doi.org/10.1080/15476910600845740	journal	January 2006
Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosis Bertolotto, Antonio Current Opinion in Neurology, Vol. 17, Issue 3 https://doi.org/10.1097/00019052-200406000-00002	journal	January 2004
Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material Fischer, Saloumeh Kadkhodayan; Cheu, Melissa; Peng, Kun The AAPS Journal, Vol. 19, Issue 1 https://doi.org/10.1208/s12248-016-9998-7	journal	October 2016
In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity Haile, Lydia A.; Puig, Montserrat; Polumuri, Swamy K. Journal of Pharmaceutical Sciences, Vol. 106, Issue 3 https://doi.org/10.1016/j.xphs.2016.11.001	journal	March 2017
CpG DNA Induces IgG Class Switch DNA Recombination by Activating Human B Cells through an Innate Pathway That Requires TLR9 and Cooperates with IL-10 He, Bing; Qiao, Xugang; Cerutti, Andrea The Journal of Immunology, Vol. 173, Issue 7 https://doi.org/10.4049/jimmunol.173.7.4479	journal	September 2004
Control of adaptive immunity by the innate immune system Iwasaki, Akiko; Medzhitov, Ruslan Nature Immunology, Vol. 16, Issue 4 https://doi.org/10.1038/ni.3123	journal	March 2015
Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells Pasare, C. Science, Vol. 299, Issue 5609 https://doi.org/10.1126/science.1078231	journal	January 2003
Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates Verthelyi, Daniela; Klinman, Dennis M. Clinical Immunology, Vol. 109, Issue 1 https://doi.org/10.1016/S1521-6616(03)00202-X	journal	October 2003
Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up Knobler, R. L.; Greenstein, J. I.; Johnson, K. P. Journal of Interferon Research, Vol. 13, Issue 5 https://doi.org/10.1089/jir.1993.13.333	journal	October 1993
Programming the magnitude and persistence of antibody responses with innate immunity Kasturi, Sudhir Pai; Skountzou, Ioanna; Albrecht, Randy A. Nature, Vol. 470, Issue 7335 https://doi.org/10.1038/nature09737	journal	February 2011
The role of glatiramer acetate in the early treatment of multiple sclerosis Brandes, David Neuropsychiatric Disease and Treatment https://doi.org/10.2147/NDT.S5898	journal	June 2010
Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins Verthelyi, Daniela; Wang, Vivian PLoS ONE, Vol. 5, Issue 12 https://doi.org/10.1371/journal.pone.0015252	journal	December 2010
Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics Jawa, Vibha; Joubert, Marisa K.; Zhang, Qingchun The AAPS Journal, Vol. 18, Issue 6 https://doi.org/10.1208/s12248-016-9948-4	journal	July 2016
Immunogenicity of An Interferon-β1a Product Kauffman, M. A.; Sterin-Prync, A.; Papouchado, M. International Journal of Immunopathology and Pharmacology, Vol. 24, Issue 2 https://doi.org/10.1177/039463201102400223	journal	April 2011

Cited By (1)

Reporter Cell Assessment of TLR4-Induced NF-κB Responses to Cell-Free Hemoglobin and the Influence of Biliverdin Sharma, Jill; Boyd, Taylor; Alvarado, Claudia Biomedicines, Vol. 7, Issue 2 https://doi.org/10.3390/biomedicines7020041	journal	June 2019

Similar Records

Staphylococcal enterotoxin C2 stimulated the maturation of bone marrow derived dendritic cells via TLR-NFκB signaling pathway

Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Experimental Cell Research · OSTI ID:1624331

Yao, Songyuan; Xu, Mingkai; Li, Yansheng; +4 more

TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension

Journal Article · Mon Aug 15 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:1624331

Li, Hong-Bao; Li, Xiang; Huo, Chan-Juan; +7 more

CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway

Journal Article · Fri Jan 02 00:00:00 EST 2015 · Biochemical and Biophysical Research Communications · OSTI ID:1624331

Wang, Yiting; Tu, Qunfei; Yan, Wei; +8 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
Science & Technology - Other Topics

Title: Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interferon beta

Citation Formats

References (52)

Cited By (1)

Similar Records

Related Subjects